SLN124

Health & Fitness

Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Volunteers

By Agnes E. Utt 5 years ago

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to